Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chronotherapy with aspirin for reduction of cardiovascular disease
2018-001328-21Phase 4Terminated
- Sponsor
- Leiden University Medical Center
- Start
- Jan 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of aspirin in cardiac morbidity, myocardial infarction (MI) and ischemic stroke (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Major adverse cardiovascular events. Started Jan 2019; status: terminated.
02
Drugs
aspirin
03
Conditions
cardiac morbiditymyocardial infarction (MI)ischemic stroke
Beyond the preview
Go deeper on 2018-001328-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001328-21.